Home Meetings Online CME/CE Clinical Resources EHR/EMR
This CME activity is co-sponsored by the American College of Physicians (ACP) and pmiCME. All decisions about the CME content and faculty are made exclusively by ACP and pmiCME. It is the goal of the organizations to provide educational opportunities that are timely, unbiased, scientifically rigorous, practical in nature, and that serve to improve patient outcomes.

Regional Conference Fort Lauderdale, FL

Location: Fort Lauderdale, FL
Date: October 8, 2014

Meeting Overview

Venue:
Greater Ft. Lauderdale/ Broward County Convention Center
Primary Audience:
Primary Care
Credits:
6.75 AMA PRA Category 1 Credits™, 6.75 AAFP or 6.75 AANP

Registration is now closed.

 

You may be interested in these other CME opportunities:

Earn CME credits in Fort Lauderdale.

As a primary care clinician, you see patients with a broad spectrum of diagnoses, questions, and needs. Spend the day learning alongside your colleagues at
Pri-Med Fort Lauderdale and gain practical clinical pearls that you can apply in your practice the very next day.

Earn up to 6.75 AMA PRA Category 1 Credits™, 6.75 AAFP Prescribed credits, or 6.75 AANP contact hours of continuing education by attending.

 
Pri-Med Show


Quality CME

The Pri-Med Fort Lauderdale CME curriculum has been developed in collaboration with the American College of Physicians to bring you practical, relevant sessions covering the variety of clinical challenges you come across in your daily practice. Learn from experts in their field as they present on:

  • Understanding the Patient with Chronic Comorbid Medical and Psychiatric Conditions
  • For Your Eyes Only - Ophthalmology 2014 Update
  • Injectable Therapies: Moving Beyond Oral Agents to Achieve Glycemic Control*

Learn More

 

Value for Your Time

Your schedule is busier than ever, so get the most out of your time away from your practice.

  • The convenient location means less time traveling and more time with your patients
  • Enjoy complimentary registration, plus coffee, light breakfast, and a boxed lunch on us
  • Earn up to 6.75 AMA PRA Category 1 Credits™, 6.75 AAFP Prescribed credits, or 6.75 AANP contact hours of continuing education by attending.

Learn More



Who Should Attend

Actively practicing primary care clinicians who are interested in timely, in-depth CME sessions to extend their learning and benefit their patients.

  • Primary care physicians
  • Nurse practitioners
  • Physician assistants
 

Industry-Sponsored Opportunities

Continue your learning during session breaks with these non-CME opportunities:

  • Attend Presentation Theaters covering the latest drugs and therapies
  • Visit the Product Forum and meet face-to-face with local industry representatives

Learn More

All Presentation Theater tickets will be distributed on-site.

Connect on Social Media

Stay in the know on upcoming programs, online offerings, and special promotions by connecting with
Pri-Med through social media:

Facebook  Twitter  LinkedIn  YouTube
Curriculum developed in collaboration
with the American College of Physicians

Curriculum developed in collaboration with the ACP

Sessions & Syllabus

New Process for Session Evaluation and Claiming Education Credit

Use this link to access the online credit system to complete the evaluation and credit request process. You have 30 days from the end of the program to complete the evaluation process.

Need a quick tutorial?

View this brief how-to video

Print Syllabus
View Schedule for:
Wednesday, October 08, 2014
6:45 AM-7:30 AM Registration and Breakfast
7:30 AM-7:45 AM Opening Remarks
7:45 AM-8:45 AM High Value Care: Informed Decisions that Reduce Waste and Improve Health Outcomes
This interactive session uses real patient cases to challenge clinicians to balance potential benefits with harms and costs of specific medical interventions

Learning Objectives:

  1. Weigh the expected clinical benefits against the costs/harms of testing and therapy when considering patient management choices.
  2. Estimate "out-of-pocket" patient expenses based on insurance status, type of plan and setting of care.
M. Susan Burke, MD, FACP, (Read Bio) , Associate Professor of Medicine, Thomas Jefferson University, Philadelphia, PA, Senior Advisor, Lankenau Medical Associates, Lankenau Medical Center, Wynnewood, PA
8:45 AM-9:45 AM Understanding the Patient with Chronic Comorbid Medical and Psychiatric Conditions
Recognize the complexities of managing patients with chronic disease and accompanying depression and/or anxiety

Learning Objectives:

  1. Identify the most common psychiatric disorders occurring in patients with medical conditions.
  2. Understand key issues in managing psychiatric disorders in patients with medical conditions.
  3. Know how to treat patients who have pain or other physical symptoms with comorbid psychiatric disorders.
  4. Consider tools and practice enhancements that improve outcomes in medical patients with psychiatric disorders.
Mark Zimmerman, MD, (Read Bio) , Professor of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, Director of Outpatient Psychiatry, Rhode Island Hospital, The Miriam Hospital, Providence, RI
9:45 AM-10:45 AM Refreshment Break and Additional Opportunities
10:45 AM-12:00 PM *Individualizing Diabetes Management with Injectable Therapies: Moving Beyond Oral Agents to Achieve Glycemic Control

Learning Objectives:

  1. Implement strategies to mitigate patient-perceived barriers to injectable therapies and explore pathways physicians can employ to overcome clinical inertia associated with type 2 diabetes mellitus (T2DM) management.
  2. Evaluate the latest clinical evidence for GLP-1 receptor agonists (GLP-1 RAs) with respect to differences among agents and potential role in combination therapy with basal insulin.
  3. Compare and contrast available insulin products and develop strategies for timely initiation, selection, intensification, and self-management of insulin therapy for T2DM based on patient specific factors.
  4. Develop a patient-centered, guidelines-based approach for intensifying T2DM therapy with injectable agents to achieve glycemic control.
Lawrence Blonde, MD, FACP, FACE, (Read Bio) , Director of the Ochsner Diabetes Clinical Research Unit, Associate Internal Medicine Residency Program Direct, Ochsner Medical Center, New Orleans, LA
Javier Morales, MD, (Read Bio) , Vice President, Principal Clinical Trials Investigator, Advanced Internal Medicine Group, PC, Great Neck, NY
12:00 PM-1:00 PM Lunch and Additional Opportunities
1:00 PM-2:15 PM *If You Don’t Test For It, You Can’t Prevent It: Key Updates in HIV Screening and Prophylaxis

Learning Objectives:

  1. Implement HIV screening procedures recommended by major health agencies in the US.
  2. Devise strategies to maximize the number of patients with HIV infection who are linked to the appropriate care upon diagnosis.
  3. Apply the newly revised guidelines for the use of Pre-Exposure Prophylaxis (PrEP) recommended by the Centers for Disease Control in at-risk populations, both male and female.
Ian Frank, MD, , Professor of Medicine, Anti-Retroviral Clinical Research, Director, Clinicla Core, Penn Center for AIDS Research, Hospital of the University of Pennsylvania, Philadelphia, PA
Ronald Cathcart, MD, , Staff Physician, Comprehensive Care Center, Melbourne, FL
2:15 PM-3:15 PM Refreshment Break
3:15 PM-4:15 PM For Your Eyes Only - Ophthalmology 2014 Update

Learning Objectives:

  1. Discuss the latest results of the CATT trial and the AREDS2 trial their implications for age-related macular degeneration.
  2. Describe how to minimize the risk of ophthalmic adverse events in patients taking alpha-blockers for prostate disease.
  3. Discuss 2 new imaging modalities designed to help primary care clinicians and ophthalmologists diagnose eye disease.
Tommy S. Korn, MD, FACS, (Read Bio) , Attending Ophthalmologist & Surgeon, Sharp Rees-Steely Surgical Eye Consultants, San Diego, CA, Attending Ophthalmologist, Sharp Rees-Stealy Medical Group, Sharp Memorial Hospital, San Diego, CA
4:15 PM-5:30 PM *A Hypoglycemia-Centric Approach to the Management of Type 2 Diabetes

Learning Objectives:

  1. Apply strategies to individualize glycemic targets in patients with type 2 diabetes.
  2. Discuss the limitations of frequently used conventional therapies for the treatment of patients with type 2 diabetes.
  3. Outline the risk factors and clinical consequences of hypoglycemia.
  4. Implement strategies to minimize hypoglycemia risk in the treatment of patients with type 2 diabetes.
Dawn Smiley, MD, , Associate Professor of Medicine, Emory University School of Medicine, Atlanta, GA
Jessica Castle, MD, , Assistant Professor, Oregon Health & Science University, Portland, OR

Ticketed Events

All Presentation Theater tickets will be distributed on-site.

View Schedule for:

Morning Break

Non-CME Presentation Theater

9:55 AM-10:40 AM

Vaccines

9:55 AM-10:40 AM

Obesity

Lunch Break

Non-CME Presentation Theater

12:10 PM-12:55 PM

Hepatitis C

12:10 PM-12:55 PM

Crohn's Disease

Afternoon Break

Non-CME Presentation Theater

2:25 PM-3:10 PM

Diabetes

2:25 PM-3:10 PM

Afib

CLOSE  X  
Pneumococcal Pneumonia and Invasive Disease in Adults: Help Protect Your Patients Aged 50+
Brought to you by: Pfizer Inc..
Room: Grand EF
Faculty:
  1. Jonathan Musher, MD
CLOSE  X  
Addressing Chronic Weight Management With Targeted Pharmacotherapy
Brought to you by: Eisai, Inc..
Room: Grand CD
Faculty:
  1. Farhad Zangeneh, MD, FACP, FACE
CLOSE  X  
Rethink HCV
Room: Grand CD
Faculty:
  1. Paul Martin, M.D., F.R.C.P., F.R.C.P.
CLOSE  X  
PCPs and IBD: A Critical Connection
Room: Grand EF
Faculty:
  1. Ronen Arai, M.D.
CLOSE  X  
Advancing Paradigm Changes in Type 2 Diabetes Management
Brought to you by: Janssen Pharmaceuticals, Inc.
Room: Grand CD
This program will cover the following topics regarding a sodium-glucose co-transporter (SGLT2) inhibitor: the role of the kidney in regulation of hyperglycemia in T2DM, the mechanism of action - mediated inhibition of SGLT2 in the proximal convoluted tubule of the kidney, key efficacy and safety data from 2 active-controlled clinical trials, important safety information, question and answer session. This promotional educational activity is sponsored by Janssen Pharmaceuticals, Inc. It is not certified for continuing medical education. 010034-140210
Faculty:
  1. Paul Jellinger, MD
CLOSE  X  
A Paradigm Shift In The Treatment of Thrombosis
Room: Grand EF
Faculty:
  1. Adam Singer, MD

Accreditation

Earn up to 6.75 AMA PRA Category 1 Credits™, 6.75 AAFP Prescribed credits, or 6.75 AANP contact hours of continuing education by attending.

Final session schedule is pending.

Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AAFP This Live activity, Pri-Med Regional Conference Ft. Lauderdale, with a beginning date of 10/08/2014, has been reviewed and is acceptable for up to 6.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education (which includes 3.500 hours of pharmacology).

Faculty

M. Susan Burke, MD, FACP (Read Bio)

Associate Professor of Medicine, Thomas Jefferson University, Philadelphia, PA
Senior Advisor, Lankenau Medical Associates, Lankenau Medical Center, Wynnewood, PA

Presenting on:

Mark Zimmerman, MD (Read Bio)

Professor of Psychiatry and Human Behavior, Brown Medical School, Providence, RI
Director of Outpatient Psychiatry, Rhode Island Hospital, The Miriam Hospital, Providence, RI

Presenting on:

Lawrence Blonde, MD, FACP, FACE (Read Bio)

Director of the Ochsner Diabetes Clinical Research Unit, Associate Internal Medicine Residency Program Direct, Ochsner Medical Center, New Orleans, LA

Presenting on:

  • Individualizing Diabetes Management with Injectable Therapies: Moving Beyond Oral Agents to Achieve Glycemic Control
    Wednesday, October 08, 2014, 10:45 AM-12:00 PM

Javier Morales, MD (Read Bio)

Vice President, Principal Clinical Trials Investigator, Advanced Internal Medicine Group, PC, Great Neck, NY

Presenting on:

  • Individualizing Diabetes Management with Injectable Therapies: Moving Beyond Oral Agents to Achieve Glycemic Control
    Wednesday, October 08, 2014, 10:45 AM-12:00 PM

Ian Frank, MD

Professor of Medicine, Anti-Retroviral Clinical Research, Director, Clinicla Core, Penn Center for AIDS Research, Hospital of the University of Pennsylvania, Philadelphia, PA

Presenting on:

  • If You Don’t Test For It, You Can’t Prevent It: Key Updates in HIV Screening and Prophylaxis
    Wednesday, October 08, 2014, 1:00 PM-2:15 PM

Ronald Cathcart, MD

Staff Physician, Comprehensive Care Center, Melbourne, FL

Presenting on:

  • If You Don’t Test For It, You Can’t Prevent It: Key Updates in HIV Screening and Prophylaxis
    Wednesday, October 08, 2014, 1:00 PM-2:15 PM

Tommy Korn, MD, FACS (Read Bio)

Attending Ophthalmologist & Surgeon, Sharp Rees-Steely Surgical Eye Consultants, San Diego, CA
Attending Ophthalmologist, Sharp Rees-Stealy Medical Group, Sharp Memorial Hospital, San Diego, CA

Presenting on:

  • For Your Eyes Only - Ophthalmology 2014 Update
    Wednesday, October 08, 2014, 3:15 PM-4:15 PM

Dawn Smiley, MD

Associate Professor of Medicine, Emory University School of Medicine, Atlanta, GA

Presenting on:

  • A Hypoglycemia-Centric Approach to the Management of Type 2 Diabetes
    Wednesday, October 08, 2014, 4:15 PM-5:30 PM

Jessica Castle, MD

Assistant Professor, Oregon Health & Science University, Portland, OR

Presenting on:

  • A Hypoglycemia-Centric Approach to the Management of Type 2 Diabetes
    Wednesday, October 08, 2014, 4:15 PM-5:30 PM

Course Directors

Course Directors Information Coming Soon.

Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Greater Ft. Lauderdale/ Broward County Convention Center
1950 Eisenhower Blvd
Fort Lauderdale, FL 33316-4205
(954) 765-5900

Hotel Accommodations

Hilton Fort Lauderdale Marina Hotel
1881 SE 17th St
Fort Lauderdale, FL 33316-3095
Phone: (800) 445-8667

A limited number of rooms have been reserved at the Hilton Fort Lauderdale Marina Hotel. Please call (800) 445-8667 by 09/15/2014 and identify yourself as a Pri-Med attendee to receive the discounted rate of $129.

Company
Exhibitors
Support
Terms
Tel: (877) 477-4633